Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

Stopped AstraZeneca has discontinued the development of AZD0530. No new AstraZeneca-sponsored clinical studies will be initiated..

Conditions

• Cancer
• Non Small Cell Lung Cancer
• Epithelial Ovarian Cancer

Interventions

• DRUG: AZD0530
• DRUG: Carboplatin
• DRUG: paclitaxel

Sponsor

AstraZeneca